Validation of predictive pharmacoeconomic model of introduction of medicinal product ibrutinib into chronic lymphatic leukemia therapy practice in the territory of the Russian Federation
2015 ◽
Vol 3
(3)
◽
pp. 42-45
◽
2019 ◽
Vol 9
(2)
◽
pp. 108-117
2021 ◽
Vol 11
(1)
◽
pp. 16-23
Keyword(s):